FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Stem Cell Rev Rep / Wharton’s Jelly Derived Mesenchymal Stem Cells: Compar...
Stem cell reviews and reports2018; 14(4); 574-584; doi: 10.1007/s12015-018-9803-3

Wharton’s Jelly Derived Mesenchymal Stem Cells: Comparing Human and Horse.

Abstract: Wharton's jelly (WJ) is an important source of mesenchymal stem cells (MSCs) both in human and other animals. The aim of this study was to compare human and equine WJMSCs. Human and equine WJMSCs were isolated and cultured using the same protocols and culture media. Cells were characterized by analysing morphology, growth rate, migration and adhesion capability, immunophenotype, differentiation potential and ultrastructure. Results showed that human and equine WJMSCs have similar ultrastructural details connected with intense synthetic and metabolic activity, but differ in growth, migration, adhesion capability and differentiation potential. In fact, at the scratch assay and transwell migration assay, the migration ability of human WJMSCs was higher (P < 0.05) than that of equine cells, while the volume of spheroids obtained after 48 h of culture in hanging drop was larger than the volume of equine ones (P < 0.05), demonstrating a lower cell adhesion ability. This can also revealed in the lower doubling time of equine cells (3.5 ± 2.4 days) as compared to human (6.5 ± 4.3 days) (P < 0.05), and subsequently in the higher number of cell doubling after 44 days of culture observed for the equine (20.3 ± 1.7) as compared to human cells (8.7 ± 2.4) (P < 0.05), and to the higher (P < 0.05) ability to form fibroblast colonies at P3. Even if in both species tri-lineage differentiation was achieved, equine cells showed an higher chondrogenic and osteogenic differentiation ability (P < 0.05). Our findings indicate that, although the ultrastructure demonstrated a staminal phenotype in human and equine WJMSCs, they showed different properties reflecting the different sources of MSCs.
Get Full Text
Publication Date: 2018-03-07 PubMed ID: 29508214DOI: 10.1007/s12015-018-9803-3Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article primarily studies and compares the characteristics of mesenchymal stem cells (MSCs) obtained from Wharton’s Jelly from humans and horses. The findings indicated that while both types of cells share similar qualities, they differ significantly in terms of growth, migration, adhesion capability, and differentiation potential.

Study Design

  • The researchers gathered mesenchymal stem cells (MSCs) from Wharton’s Jelly (WJ) of both horses and humans.
  • The cells from both sources were isolated and cultivated using identical protocols and culture mediums.
  • The researchers then compared and analyzed their morphology, growth rate, ability to migrate and adhere, immunophenotype, potential to differentiate, and ultrastructure.

Results

  • The study results showed that the MSCs from both species looked similar at an ultrastructural level and were involved in high metabolic and synthetic activities.
  • However, the cells differed in their growth rate, migration capability, capacity to adhere, and potential to differentiate.
  • The migration potential of human MSCs was significantly higher than that of the equine MSCs.
  • Human spheroids (cell clusters) after 48 hours of hanging drop culture were larger, indicating a lower adhesion capacity in equine cells.
  • Equine cells presented a faster doubling time than human cells, indicating a higher growth rate, and had a larger number of cell doublings after 44 days of culture.
  • Equine MSCs also performed better at forming fibroblast colonies at Passage 3 (P3) in the absence of serum.
  • Although tri-lineage differentiation (where a stem cell differentiates into three distinct cell types) was achieved in both human and horse cells, the horse’s cells showed higher capacity for chondrogenic and osteogenic differentiation.

Conclusion

  • The results suggest that although human and equine MSCs from Wharton’s Jelly share certain qualities, they display different characteristics due to their different origins.
  • This has potential implications in the fields of cell biology and regenerative medicine where understanding the exact nature and abilities of stem cells is important.

Cite This Article

APA
Merlo B, Teti G, Mazzotti E, Ingrà L, Salvatore V, Buzzi M, Cerqueni G, Dicarlo M, Lanci A, Castagnetti C, Iacono E. (2018). Wharton’s Jelly Derived Mesenchymal Stem Cells: Comparing Human and Horse. Stem Cell Rev Rep, 14(4), 574-584. https://doi.org/10.1007/s12015-018-9803-3

Publication

Stem cell reviews and reports
ISSN: 2629-3277
NlmUniqueID: 101752767
Country: United States
Language: English
Volume: 14
Issue: 4
Pages: 574-584

Researcher Affiliations

Merlo, Barbara
  • Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064, Ozzano Emilia, BO, Italy. barbara.merlo@unibo.it.
Teti, Gabriella
  • Department for Biomedical and Neuromotor Sciences, University of Bologna, via Irnerio 48, 40126, Bologna, BO, Italy.
Mazzotti, Eleonora
  • Department of Comparative Biomedical Sciences, University of Teramo, via R. Balzarini 1, 64100, Teramo, TE, Italy.
Ingrà, Laura
  • Department for Biomedical and Neuromotor Sciences, University of Bologna, via Irnerio 48, 40126, Bologna, BO, Italy.
Salvatore, Viviana
  • An2H Discovery Limited, National Institute for Cellular Bioetchnology (NICB), Dublin City University Campus, Glasnevin, Dublin 9, Ireland.
Buzzi, Marina
  • Banca dei Tessuti, del Sangue cordonale e Biobanca Policlinico S.Orsola-Malpighi, Bologna, Italy.
Cerqueni, Giorgia
  • Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.
Dicarlo, Manuela
  • Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.
Lanci, Aliai
  • Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064, Ozzano Emilia, BO, Italy.
Castagnetti, Carolina
  • Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064, Ozzano Emilia, BO, Italy.
Iacono, Eleonora
  • Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064, Ozzano Emilia, BO, Italy.

MeSH Terms

  • Animals
  • Cell Adhesion
  • Cell Differentiation
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Chondrogenesis
  • Horses
  • Humans
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / ultrastructure
  • Microscopy, Electron, Transmission
  • Osteogenesis
  • Species Specificity
  • Wharton Jelly / cytology

Grant Funding

  • RFO (Ricerca Fondamentale Orientata) / Universitu00e0 di Bologna

References

This article includes 28 references
  1. De Schauwer C, Meyer E, Van de Walle GR, Van Soom A. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity.. Theriogenology 2011 May;75(8):1431-43.
    pubmed: 21196039doi: 10.1016/j.theriogenology.2010.11.008google scholar: lookup
  2. Vangsness CT Jr, Sternberg H, Harris L. Umbilical Cord Tissue Offers the Greatest Number of Harvestable Mesenchymal Stem Cells for Research and Clinical Application: A Literature Review of Different Harvest Sites.. Arthroscopy 2015 Sep;31(9):1836-43.
    pubmed: 26354202doi: 10.1016/j.arthro.2015.03.014google scholar: lookup
  3. Pasquinelli G, Tazzari P, Ricci F, Vaselli C, Buzzi M, Conte R, Orrico C, Foroni L, Stella A, Alviano F, Bagnara GP, Lucarelli E. Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta.. Ultrastruct Pathol 2007 Jan-Feb;31(1):23-31.
    pubmed: 17455095doi: 10.1080/01913120601169477google scholar: lookup
  4. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population.. Stem Cells 2008 Mar;26(3):591-9.
    pubmed: 18065397doi: 10.1634/stemcells.2007-0439google scholar: lookup
  5. Li G, Zhang XA, Wang H, Wang X, Meng CL, Chan CY, Yew DT, Tsang KS, Li K, Tsai SN, Ngai SM, Han ZC, Lin MC, He ML, Kung HF. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration.. Proteomics 2009 Jan;9(1):20-30.
    pubmed: 19116983doi: 10.1002/pmic.200701195google scholar: lookup
  6. Janderová L, McNeil M, Murrell AN, Mynatt RL, Smith SR. Human mesenchymal stem cells as an in vitro model for human adipogenesis.. Obes Res 2003 Jan;11(1):65-74.
    pubmed: 12529487doi: 10.1038/oby.2003.11google scholar: lookup
  7. Patterson-Kane JC, Becker DL, Rich T. The pathogenesis of tendon microdamage in athletes: the horse as a natural model for basic cellular research.. J Comp Pathol 2012 Aug-Oct;147(2-3):227-47.
    pubmed: 22789861doi: 10.1016/j.jcpa.2012.05.010google scholar: lookup
  8. Orsolic I, Jurada D, Pullen N, Oren M, Eliopoulos AG, Volarevic S. The relationship between the nucleolus and cancer: Current evidence and emerging paradigms.. Semin Cancer Biol 2016 Jun;37-38:36-50.
    pubmed: 26721423doi: 10.1016/j.semcancer.2015.12.004google scholar: lookup
  9. Pascucci L, Mercati F, Marini C, Ceccarelli P, Dall'Aglio C, Pedini V, Gargiulo AM. Ultrastructural morphology of equine adipose-derived mesenchymal stem cells.. Histol Histopathol 2010 Oct;25(10):1277-85.
    pubmed: 20712012doi: 10.14670/HH-25.1277google scholar: lookup
  10. Rainaldi G, Pinto B, Piras A, Vatteroni L, Simi S, Citti L. Reduction of proliferative heterogeneity of CHEF18 Chinese hamster cell line during the progression toward tumorigenicity.. In Vitro Cell Dev Biol 1991 Dec;27A(12):949-52.
    pubmed: 1757399doi: 10.1007/BF02631122google scholar: lookup
  11. Suzuki S, Muneta T, Tsuji K, Ichinose S, Makino H, Umezawa A, Sekiya I. Properties and usefulness of aggregates of synovial mesenchymal stem cells as a source for cartilage regeneration.. Arthritis Res Ther 2012 Jun 7;14(3):R136.
    pubmed: 22676383doi: 10.1186/ar3869google scholar: lookup
  12. Crovace A, Lacitignola L, Rossi G, Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon.. Vet Med Int 2010;2010:250978.
    pubmed: 20445779doi: 10.4061/2010/250978google scholar: lookup
  13. Smith RK. Mesenchymal stem cell therapy for equine tendinopathy.. Disabil Rehabil 2008;30(20-22):1752-8.
    pubmed: 18608378doi: 10.1080/09638280701788241google scholar: lookup
  14. Iacono E, Rossi B, Merlo B. Stem cells from foetal adnexa and fluid in domestic animals: an update on their features and clinical application.. Reprod Domest Anim 2015 Jun;50(3):353-64.
    pubmed: 25703812doi: 10.1111/rda.12499google scholar: lookup
  15. Wang W, Itaka K, Ohba S, Nishiyama N, Chung UI, Yamasaki Y, Kataoka K. 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells.. Biomaterials 2009 May;30(14):2705-15.
    pubmed: 19215979doi: 10.1016/j.biomaterials.2009.01.030google scholar: lookup
  16. De Schauwer C, Piepers S, Van de Walle GR, Demeyere K, Hoogewijs MK, Govaere JL, Braeckmans K, Van Soom A, Meyer E. In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry.. Cytometry A 2012 Apr;81(4):312-23.
    pubmed: 22411893doi: 10.1002/cyto.a.22026google scholar: lookup
  17. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    pubmed: 16923606doi: 10.1080/14653240600855905google scholar: lookup
  18. Harding J, Roberts RM, Mirochnitchenko O. Large animal models for stem cell therapy.. Stem Cell Res Ther 2013 Mar 28;4(2):23.
    pubmed: 23672797doi: 10.1186/scrt171google scholar: lookup
  19. Ibrahim S, Steinbach F. Immunoprecipitation of equine CD molecules using anti-human MABs previously analyzed by flow cytometry and immunohistochemistry.. Vet Immunol Immunopathol 2012 Jan 15;145(1-2):7-13.
    pubmed: 22070824doi: 10.1016/j.vetimm.2011.07.021google scholar: lookup
  20. Piccinini F, Tesei A, Arienti C, Bevilacqua A. Cancer multicellular spheroids: volume assessment from a single 2D projection.. Comput Methods Programs Biomed 2015 Feb;118(2):95-106.
    pubmed: 25561413doi: 10.1016/j.cmpb.2014.12.003google scholar: lookup
  21. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012 Jan;44(1):25-32.
    pubmed: 21615465doi: 10.1111/j.2042-3306.2011.00363.xgoogle scholar: lookup
  22. Iacono E, Brunori L, Pirrone A, Pagliaro PP, Ricci F, Tazzari PL, Merlo B. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.. Reproduction 2012 Apr;143(4):455-68.
    pubmed: 22274885doi: 10.1530/REP-10-0408google scholar: lookup
  23. Sart S, Tsai AC, Li Y, Ma T. Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications.. Tissue Eng Part B Rev 2014 Oct;20(5):365-80.
    pubmed: 24168395doi: 10.1089/ten.TEB.2013.0537google scholar: lookup
  24. Sbrana FV, Cortini M, Avnet S, Perut F, Columbaro M, De Milito A, Baldini N. The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells.. Stem Cell Rev Rep 2016 Dec;12(6):621-633.
    pubmed: 27696271doi: 10.1007/s12015-016-9690-4google scholar: lookup
  25. García-Prat L, Martínez-Vicente M, Muñoz-Cánoves P. Autophagy: a decisive process for stemness.. Oncotarget 2016 Mar 15;7(11):12286-8.
    pubmed: 26934325doi: 10.18632/oncotarget.7766google scholar: lookup
  26. Mizuno H, Hyakusoku H. Mesengenic potential and future clinical perspective of human processed lipoaspirate cells.. J Nippon Med Sch 2003 Aug;70(4):300-6.
    pubmed: 12928709doi: 10.1272/jnms.70.300google scholar: lookup
  27. Teti G, Cavallo C, Grigolo B, Giannini S, Facchini A, Mazzotti A, Falconi M. Ultrastructural analysis of human bone marrow mesenchymal stem cells during in vitro osteogenesis and chondrogenesis.. Microsc Res Tech 2012 May;75(5):596-604.
    pubmed: 21998022doi: 10.1002/jemt.21096google scholar: lookup
  28. Mattioli-Belmonte M, Teti G, Salvatore V, Focaroli S, Orciani M, Dicarlo M, Fini M, Orsini G, Di Primio R, Falconi M. Stem cell origin differently affects bone tissue engineering strategies.. Front Physiol 2015;6:266.
    pubmed: 26441682doi: 10.3389/fphys.2015.00266google scholar: lookup

Citations

This article has been cited 7 times.
  1. Carano F, Teti G, Ruggeri A, Chiarini F, Giorgetti A, Mazzotti MC, Fais P, Falconi M. Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine.. Sci Rep 2021 Sep 28;11(1):19248.
    doi: 10.1038/s41598-021-98682-6pubmed: 34584173google scholar: lookup
  2. Marcoccia R, Nesci S, Merlo B, Ballotta G, Algieri C, Pagliarani A, Iacono E. Biological characteristics and metabolic profile of canine mesenchymal stem cells isolated from adipose tissue and umbilical cord matrix.. PLoS One 2021;16(3):e0247567.
    doi: 10.1371/journal.pone.0247567pubmed: 33661930google scholar: lookup
  3. Ramallo M, Carreras-Sánchez I, López-Fernández A, Vélez R, Aguirre M, Feldman S, Vives J. Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord.. Histol Histopathol 2021 Jan;36(1):19-30.
    doi: 10.14670/HH-18-249pubmed: 32914860google scholar: lookup
  4. Weiss C, Kornicka-Grabowska K, Mularczyk M, Siwinska N, Marycz K. Extracellular Microvesicles (MV's) Isolated from 5-Azacytidine-and-Resveratrol-Treated Cells Improve Viability and Ameliorate Endoplasmic Reticulum Stress in Metabolic Syndrome Derived Mesenchymal Stem Cells.. Stem Cell Rev Rep 2020 Dec;16(6):1343-1355.
    doi: 10.1007/s12015-020-10035-4pubmed: 32880856google scholar: lookup
  5. Mazzotti E, Teti G, Falconi M, Chiarini F, Barboni B, Mazzotti A, Muttini A. Age-Related Alterations Affecting the Chondrogenic Differentiation of Synovial Fluid Mesenchymal Stromal Cells in an Equine Model.. Cells 2019 Sep 20;8(10).
    doi: 10.3390/cells8101116pubmed: 31547126google scholar: lookup
  6. Merlo B, Teti G, Lanci A, Burk J, Mazzotti E, Falconi M, Iacono E. Comparison between adult and foetal adnexa derived equine post-natal mesenchymal stem cells.. BMC Vet Res 2019 Aug 2;15(1):277.
    doi: 10.1186/s12917-019-2023-5pubmed: 31375144google scholar: lookup
  7. Mattioli-Belmonte M, Montemurro F, Licini C, Iezzi I, Dicarlo M, Cerqueni G, Coro F, Vozzi G. Cell-Free Demineralized Bone Matrix for Mesenchymal Stem Cells Survival and Colonization.. Materials (Basel) 2019 Apr 26;12(9).
    doi: 10.3390/ma12091360pubmed: 31027339google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.